— Know what they know.
Not Investment Advice

CBDY OTC

Target Group Inc.
1W: -12.5% 1M: -30.0% 3M: -41.7% YTD: -53.3% 1Y: -58.8% 3Y: -89.5% 5Y: -96.1%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 44 · $431918 mcap · 555M float · 0.042% daily turnover · Short 55% of daily vol

Income Trends

Revenue
$7M +77.2% ▲
Gross Profit
$4M +125.1% ▲
Operating Income
$1M +195.2% ▲
Net Income
$161K +149.5% ▲
EPS (Diluted)
$0.00 +140.0% ▲
EBITDA
$2M +17.4% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$30K$0$0$4M$7M
YoY Growth+0.0%-100.0%+0.0%+0.0%+77.2%
Cost of Revenue$25K$972K$885K$2M$3M
Gross Profit$5K-$972K-$885K$2M$4M
Gross Margin16.7%——44.5%56.5%
R&D Expenses$0$0$0$0$0
SG&A Expenses$989K$356K$244K$1M$2M
Operating Expenses$2M$359K$453K$2M$2M
Operating Income-$2M-$378K-$453K$380K$1M
Operating Margin-5236.7%——10.2%17.0%
Interest Expense$542K$986K$1M$1M$1M
Income Before Tax-$7M$273K-$5M-$324K$161K
Tax Expense$0$0$0$0$0
Net Income-$7M-$471K-$5M-$324K$161K
Net Margin-23580.0%——-8.7%2.4%
EPS (Diluted)$-0.01$-0.00$-0.01$-0.00$0.00
EBITDA-$6M-$359K-$453K$2M$2M
Shares Outstanding567M595M617M617M727M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms